HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $458,000 | -57.8% | 240,221 | +9.9% | 0.00% | -60.0% |
| Q1 2022 | $1,086,000 | +60.7% | 218,663 | +144.1% | 0.01% | +66.7% |
| Q4 2021 | $676,000 | +1.5% | 89,590 | +6.3% | 0.01% | -14.3% |
| Q3 2021 | $666,000 | -19.6% | 84,272 | +41.1% | 0.01% | -22.2% |
| Q2 2021 | $828,000 | -35.9% | 59,724 | -3.2% | 0.01% | -43.8% |
| Q1 2021 | $1,291,000 | – | 61,698 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $24,938,000 | 7.19% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $24,738,000 | 5.73% |
| MPM BioImpact LLC | 3,196,707 | $25,254,000 | 3.92% |
| Affinity Asset Advisors, LLC | 250,000 | $1,975,000 | 0.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 215,000 | $1,696,000 | 0.41% |
| Orbimed Advisors | 2,611,308 | $20,629,000 | 0.23% |
| DAFNA Capital Management LLC | 105,163 | $831,000 | 0.22% |
| Avidity Partners Management LP | 1,190,600 | $9,406,000 | 0.21% |
| Artal Group S.A. | 1,000,000 | $7,900,000 | 0.18% |
| Cormorant Asset Management, LP | 540,600 | $4,271,000 | 0.17% |